Breaking News Instant updates and real-time market news.

NFLX

Netflix

$309.99 /

-4.69 (-1.49%)

05:37
12/03/19
12/03
05:37
12/03/19
05:37

Netflix downgraded to Neutral from Buy with coverage transfer at Citi

Citi analyst Jason Bazinet downgraded Netflix to Neutral from Buy with a price target of $325, down from $410, after taking over coverage of the name. The stock closed Monday down $4.67 to $309.99. The analyst says consensus estimates are too high. Over the last seven years, there is a strong historical relationship between the company's cash outlays on content and its net subscriber additions, Bazinet tells investors in a research note. However, Street forecasts "materially deviate from this long-term pattern," contends the analyst. He believes this suggests Netflix's cash content costs need to rise, or net add forecasts need to fall. Bazinet's numbers suggest that if content costs rise, Netflix shares could fall 15%. If net add forecasts come down, the stock could fall 5%, adds the analyst.

  • 09

    Dec

  • 10

    Dec

NFLX Netflix
$309.99 /

-4.69 (-1.49%)

11/25/19
Fly Intel: Top five analyst downgrades
11/25/19 Wells Fargo
Wells Fargo downgrades Netflix to Underperform on 'expensive' subscriber growth
11/25/19 Wells Fargo
Netflix downgraded to Underperform from Market Perform at Wells Fargo
11/22/19 Nomura
Netflix seeing 'muted' impact from Disney+ launch, says Nomura Instinet

TODAY'S FREE FLY STORIES

Earnings
Axos Financial reports Q1 adjusted EPS 91c, consensus 68c » 16:33
10/29/20
10/29
16:33
10/29/20
16:33
AX

Axos Financial

$26.18 /

+0.195 (+0.75%)

"Our diverse…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AX Axos Financial
$26.18 /

+0.195 (+0.75%)

AX Axos Financial
$26.18 /

+0.195 (+0.75%)

04/30/20 Wedbush
Axos Financial price target raised to $27 from $21 at Wedbush
01/09/20 B. Riley FBR
Axos, Meta Financial among FBR's top Banks & Thrifts picks for 2020
12/18/19
Fly Intel: Top five analyst initiations
12/17/19 Wedbush
Axos Financial initiated with an Outperform at Wedbush
AX Axos Financial
$26.18 /

+0.195 (+0.75%)

AX Axos Financial
$26.18 /

+0.195 (+0.75%)

Earnings
Proofpoint sees FY20 EPS $1.88 -$1.91, consensus $1.68 » 16:33
10/29/20
10/29
16:33
10/29/20
16:33
PFPT

Proofpoint

$103.00 /

-1.27 (-1.22%)

Sees FY20 revenue $1.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFPT Proofpoint
$103.00 /

-1.27 (-1.22%)

PFPT Proofpoint
$103.00 /

-1.27 (-1.22%)

10/26/20 DA Davidson
Proofpoint price target lowered to $124 from $155 at DA Davidson
08/26/20 Wedbush
Proofpoint assumed with an Outperform at Wedbush
08/19/20
Fly Intel: Top five analyst upgrades
08/19/20 Morgan Stanley
Proofpoint upgraded to Overweight from Equal Weight at Morgan Stanley
PFPT Proofpoint
$103.00 /

-1.27 (-1.22%)

Earnings
Archer Daniels reports Q3 EPS 89c, consensus 71c » 16:32
10/29/20
10/29
16:32
10/29/20
16:32
ADM

Archer Daniels

$49.95 /

+0.45 (+0.91%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADM Archer Daniels
$49.95 /

+0.45 (+0.91%)

ADM Archer Daniels
$49.95 /

+0.45 (+0.91%)

10/26/20
Fly Intel: Top five analyst upgrades
10/26/20 Monness Crespi
Archer Daniels upgraded to Buy ahead of earnings at Monness Crespi
10/26/20 Monness Crespi
Archer Daniels upgraded to Buy from Neutral at Monness Crespi
10/19/20
Fly Intel: Top five analyst upgrades
ADM Archer Daniels
$49.95 /

+0.45 (+0.91%)

ADM Archer Daniels
$49.95 /

+0.45 (+0.91%)

ADM Archer Daniels
$49.95 /

+0.45 (+0.91%)

ADM Archer Daniels
$49.95 /

+0.45 (+0.91%)

Hot Stocks
Radian Group announces wind down of traditional appraisal business » 16:32
10/29/20
10/29
16:32
10/29/20
16:32
RDN

Radian Group

$17.36 /

+0.37 (+2.18%)

Radian Group said that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RDN Radian Group
$17.36 /

+0.37 (+2.18%)

RDN Radian Group
$17.36 /

+0.37 (+2.18%)

10/12/20 Susquehanna
Earning should propel mortgage insurers higher, says Susquehanna
10/06/20 Keefe Bruyette
Radian Group upgraded to Outperform from Market Perform at Keefe Bruyette
10/05/20 BTIG
Radian Group trades at discount valuation despite improving trends, says BTIG
06/09/20 Keefe Bruyette
Radian Group downgraded to Market Perform from Outperform at Keefe Bruyette
RDN Radian Group
$17.36 /

+0.37 (+2.18%)

RDN Radian Group
$17.36 /

+0.37 (+2.18%)

Hot Stocks
Apple maintains target of reaching net cash neutral position over time » 16:32
10/29/20
10/29
16:32
10/29/20
16:32
AAPL

Apple

$114.52 /

+3.37 (+3.03%)

Luca Maestri,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$114.52 /

+3.37 (+3.03%)

AAPL Apple
$114.52 /

+3.37 (+3.03%)

10/27/20 Wedbush
Apple should post at least modest upside to Street's $64B estimate, says Wedbush
10/27/20 Credit Suisse
Later-than-normal Apple iPhone launch pushes revenue to Q4, says Credit Suisse
10/26/20 Loop Capital
Apple price target lowered to $115 from $135 at Loop Capital
10/26/20 Deutsche Bank
Apple may not feel comfortable issuing guidance, says Deutsche Bank
AAPL Apple
$114.52 /

+3.37 (+3.03%)

AAPL Apple
$114.52 /

+3.37 (+3.03%)

AAPL Apple
$114.52 /

+3.37 (+3.03%)

AAPL Apple
$114.52 /

+3.37 (+3.03%)

AAPL Apple
$114.52 /

+3.37 (+3.03%)

Hot Stocks
Bio-Rad sees FY20 currency neutral sales up 5.9%-6.3% y/y » 16:32
10/29/20
10/29
16:32
10/29/20
16:32
BIO

Bio-Rad

$568.15 /

+2.33 (+0.41%)

The company currently…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BIO Bio-Rad
$568.15 /

+2.33 (+0.41%)

BIO Bio-Rad
$568.15 /

+2.33 (+0.41%)

07/31/20 Wells Fargo
Bio-Rad price target raised to $590 from $525 at Wells Fargo
07/31/20 Citi
Bio-Rad price target raised to $625 from $525 at Citi
05/21/20 Wells Fargo
Bio-Rad price target raised to $525 from $495 at Wells Fargo
04/08/20 Jefferies
Bio-Rad COVID-19 antibody test 'could be big,' says Jefferies
BIO Bio-Rad
$568.15 /

+2.33 (+0.41%)

Earnings
Select Medical reports Q3 adjusted EPS 56c, consensus 29c » 16:32
10/29/20
10/29
16:32
10/29/20
16:32
SEM

Select Medical

$22.01 /

+0.61 (+2.85%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SEM Select Medical
$22.01 /

+0.61 (+2.85%)

SEM Select Medical
$22.01 /

+0.61 (+2.85%)

08/04/20 Deutsche Bank
Select Medical price target raised to $26 from $24 at Deutsche Bank
06/16/20 BofA
Select Medical downgraded to Underperform from Neutral at BofA
06/16/20 BofA
Select Medical downgraded to Underperform from Neutral at BofA
05/04/20 Wells Fargo
Select Medical price target lowered to $24 from $31 at Wells Fargo
SEM Select Medical
$22.01 /

+0.61 (+2.85%)

Earnings
Cheesecake Factory reports Q3 adjusted EPS (33c), consensus (42c) » 16:32
10/29/20
10/29
16:32
10/29/20
16:32
CAKE

Cheesecake Factory

$29.96 /

+0.92 (+3.17%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CAKE Cheesecake Factory
$29.96 /

+0.92 (+3.17%)

CAKE Cheesecake Factory
$29.96 /

+0.92 (+3.17%)

10/20/20 JPMorgan
Cheesecake Factory price target raised to $33 from $24 at JPMorgan
10/19/20 Wells Fargo
Cheesecake Factory price target raised to $37 from $30 at Wells Fargo
09/18/20 Piper Sandler
Cheesecake Factory price target raised to $38 from $30 at Piper Sandler
08/03/20 BofA
Cheesecake Factory downgraded to Underperform from Neutral at BofA
CAKE Cheesecake Factory
$29.96 /

+0.92 (+3.17%)

CAKE Cheesecake Factory
$29.96 /

+0.92 (+3.17%)

CAKE Cheesecake Factory
$29.96 /

+0.92 (+3.17%)

Earnings
Forrester sees Q4 adjusted EPS 27c-34c, consensus 18c » 16:32
10/29/20
10/29
16:32
10/29/20
16:32
FORR

Forrester

$37.96 /

+2.17 (+6.06%)

Sees Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FORR Forrester
$37.96 /

+2.17 (+6.06%)

08/03/20 Barrington
Forrester price target raised to $44 from $40 at Barrington
03/31/20 Barrington
Forrester upgraded to Outperform from Market Perform at Barrington
FORR Forrester
$37.96 /

+2.17 (+6.06%)

Earnings
Builders FirstSource reports Q3 adjusted EPS 82c, consensus 64c » 16:32
10/29/20
10/29
16:32
10/29/20
16:32
BLDR

Builders FirstSource

$30.03 /

-0.5 (-1.64%)

Reports Q3 revenue $2.3B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BLDR Builders FirstSource
$30.03 /

-0.5 (-1.64%)

BLDR Builders FirstSource
$30.03 /

-0.5 (-1.64%)

10/12/20 Barclays
Builders FirstSource price target raised to $39 from $36 at Barclays
09/30/20 DA Davidson
BMC Stock Holdings price target raised to $50 from $35 at DA Davidson
08/28/20
Fly Intel: Top five analyst upgrades
08/28/20 Wedbush
BMC Stock Holdings downgraded to Neutral from Outperform at Wedbush
BLDR Builders FirstSource
$30.03 /

-0.5 (-1.64%)

BLDR Builders FirstSource
$30.03 /

-0.5 (-1.64%)

BLDR Builders FirstSource
$30.03 /

-0.5 (-1.64%)

Earnings
Bio-Rad reports Q3 adjusted EPS $3.00, consensus $1.80 » 16:32
10/29/20
10/29
16:32
10/29/20
16:32
BIO

Bio-Rad

$568.15 /

+2.33 (+0.41%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BIO Bio-Rad
$568.15 /

+2.33 (+0.41%)

BIO Bio-Rad
$568.15 /

+2.33 (+0.41%)

07/31/20 Wells Fargo
Bio-Rad price target raised to $590 from $525 at Wells Fargo
07/31/20 Citi
Bio-Rad price target raised to $625 from $525 at Citi
05/21/20 Wells Fargo
Bio-Rad price target raised to $525 from $495 at Wells Fargo
04/08/20 Jefferies
Bio-Rad COVID-19 antibody test 'could be big,' says Jefferies
BIO Bio-Rad
$568.15 /

+2.33 (+0.41%)

Hot Stocks
Apple says early response to new products 'tremendously positive' » 16:31
10/29/20
10/29
16:31
10/29/20
16:31
AAPL

Apple

$114.52 /

+3.37 (+3.03%)

Apple CEO Tim Cook said…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$114.52 /

+3.37 (+3.03%)

AAPL Apple
$114.52 /

+3.37 (+3.03%)

10/27/20 Wedbush
Apple should post at least modest upside to Street's $64B estimate, says Wedbush
10/27/20 Credit Suisse
Later-than-normal Apple iPhone launch pushes revenue to Q4, says Credit Suisse
10/26/20 Loop Capital
Apple price target lowered to $115 from $135 at Loop Capital
10/26/20 Deutsche Bank
Apple may not feel comfortable issuing guidance, says Deutsche Bank
AAPL Apple
$114.52 /

+3.37 (+3.03%)

AAPL Apple
$114.52 /

+3.37 (+3.03%)

AAPL Apple
$114.52 /

+3.37 (+3.03%)

AAPL Apple
$114.52 /

+3.37 (+3.03%)

AAPL Apple
$114.52 /

+3.37 (+3.03%)

Earnings
Cavco Industries reports Q2 EPS $1.62, consensus $1.50 » 16:31
10/29/20
10/29
16:31
10/29/20
16:31
CVCO

Cavco Industries

$178.08 /

+3.2 (+1.83%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CVCO Cavco Industries
$178.08 /

+3.2 (+1.83%)

09/23/20 Craig-Hallum
Cavco Industries upgraded to Buy from Hold at Craig-Hallum
08/04/20 Craig-Hallum
Cavco Industries price target raised to $218 from $204 at Craig-Hallum
07/14/20
Fly Intel: Top five analyst initiations
07/14/20 Wedbush
Cavco Industries initiated with a Neutral on valuation at Wedbush
CVCO Cavco Industries
$178.08 /

+3.2 (+1.83%)

Earnings
Forrester raises FY20 adjusted EPS view to $1.53-$1.60 from $1.15-$1.40 » 16:30
10/29/20
10/29
16:30
10/29/20
16:30
FORR

Forrester

$37.96 /

+2.17 (+6.06%)

Consensus for FY20 EPS is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FORR Forrester
$37.96 /

+2.17 (+6.06%)

08/03/20 Barrington
Forrester price target raised to $44 from $40 at Barrington
03/31/20 Barrington
Forrester upgraded to Outperform from Market Perform at Barrington
FORR Forrester
$37.96 /

+2.17 (+6.06%)

Earnings
Columbia Sportswear sees Q4 EPS $1.07-$1.32, consensus $1.59 » 16:30
10/29/20
10/29
16:30
10/29/20
16:30
COLM

Columbia Sportswear

$96.26 /

+2.5 (+2.67%)

Sees Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
COLM Columbia Sportswear
$96.26 /

+2.5 (+2.67%)

COLM Columbia Sportswear
$96.26 /

+2.5 (+2.67%)

10/21/20 Wedbush
Columbia Sportswear price target raised to $103 from $95 at Wedbush
10/12/20 UBS
Columbia Sportswear initiated with a Neutral at UBS
10/07/20 RBC Capital
Canada Goose price target raised to C$47 from C$43 at RBC Capital
08/27/20 Wedbush
Columbia Sportswear price target raised to $95 from $88 at Wedbush
COLM Columbia Sportswear
$96.26 /

+2.5 (+2.67%)

COLM Columbia Sportswear
$96.26 /

+2.5 (+2.67%)

Earnings
Fortress Transportation reports Q3 EPS (30c), consensus (14c) » 16:30
10/29/20
10/29
16:30
10/29/20
16:30
FTAI

Fortress Transportation

$16.66 /

+0.24 (+1.46%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FTAI Fortress Transportation
$16.66 /

+0.24 (+1.46%)

FTAI Fortress Transportation
$16.66 /

+0.24 (+1.46%)

10/19/20 Compass Point
Fortress Transportation initiated with a Buy at Compass Point
09/03/20 B. Riley FBR
Fortress Transportation transferred with Buy rating at B. Riley FBR
07/17/20 Benchmark
Fortress Transportation initiated with a Buy at Benchmark
12/02/19 BTIG
Fortress Transportation initiated with a Buy at BTIG
FTAI Fortress Transportation
$16.66 /

+0.24 (+1.46%)

FTAI Fortress Transportation
$16.66 /

+0.24 (+1.46%)

Earnings
Apple reports Q4 EPS 73c, consensus 70c » 16:30
10/29/20
10/29
16:30
10/29/20
16:30
AAPL

Apple

$114.52 /

+3.37 (+3.03%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$114.52 /

+3.37 (+3.03%)

AAPL Apple
$114.52 /

+3.37 (+3.03%)

10/27/20 Wedbush
Apple should post at least modest upside to Street's $64B estimate, says Wedbush
10/27/20 Credit Suisse
Later-than-normal Apple iPhone launch pushes revenue to Q4, says Credit Suisse
10/26/20 Loop Capital
Apple price target lowered to $115 from $135 at Loop Capital
10/26/20 Deutsche Bank
Apple may not feel comfortable issuing guidance, says Deutsche Bank
AAPL Apple
$114.52 /

+3.37 (+3.03%)

AAPL Apple
$114.52 /

+3.37 (+3.03%)

AAPL Apple
$114.52 /

+3.37 (+3.03%)

AAPL Apple
$114.52 /

+3.37 (+3.03%)

AAPL Apple
$114.52 /

+3.37 (+3.03%)

Earnings
Proofpoint sees Q4 EPS 41c-44c, consensus 39c » 16:30
10/29/20
10/29
16:30
10/29/20
16:30
PFPT

Proofpoint

$103.00 /

-1.27 (-1.22%)

Sees Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFPT Proofpoint
$103.00 /

-1.27 (-1.22%)

PFPT Proofpoint
$103.00 /

-1.27 (-1.22%)

10/26/20 DA Davidson
Proofpoint price target lowered to $124 from $155 at DA Davidson
08/26/20 Wedbush
Proofpoint assumed with an Outperform at Wedbush
08/19/20
Fly Intel: Top five analyst upgrades
08/19/20 Morgan Stanley
Proofpoint upgraded to Overweight from Equal Weight at Morgan Stanley
PFPT Proofpoint
$103.00 /

-1.27 (-1.22%)

Earnings
Regional Management reports Q3 EPS $1.01, consensus 55c » 16:30
10/29/20
10/29
16:30
10/29/20
16:30
RM

Regional Management

$19.82 /

+0.05 (+0.25%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RM Regional Management
$19.82 /

+0.05 (+0.25%)

RM Regional Management
$19.82 /

+0.05 (+0.25%)

05/14/20 BMO Capital
BMO Capital upgrades Regional Management to Outperform, sees potential to double
05/14/20 BMO Capital
Regional Management upgraded to Outperform from Market Perform at BMO Capital
05/07/20 JMP Securities
Regional Management price target lowered to $20 from $35 at JMP Securities
RM Regional Management
$19.82 /

+0.05 (+0.25%)

Options
Preliminary option volume of 28.9M today » 16:30
10/29/20
10/29
16:30
10/29/20
16:30

Preliminary option volume…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Earnings
Columbia Sportswear reports Q3 EPS 94c, consensus $1.16 » 16:29
10/29/20
10/29
16:29
10/29/20
16:29
COLM

Columbia Sportswear

$96.26 /

+2.5 (+2.67%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
COLM Columbia Sportswear
$96.26 /

+2.5 (+2.67%)

COLM Columbia Sportswear
$96.26 /

+2.5 (+2.67%)

10/21/20 Wedbush
Columbia Sportswear price target raised to $103 from $95 at Wedbush
10/12/20 UBS
Columbia Sportswear initiated with a Neutral at UBS
10/07/20 RBC Capital
Canada Goose price target raised to C$47 from C$43 at RBC Capital
08/27/20 Wedbush
Columbia Sportswear price target raised to $95 from $88 at Wedbush
COLM Columbia Sportswear
$96.26 /

+2.5 (+2.67%)

COLM Columbia Sportswear
$96.26 /

+2.5 (+2.67%)

Syndicate
Plus Therapeutics files to sell 1.52M shares of common stock for holders  16:29
10/29/20
10/29
16:29
10/29/20
16:29
PSTV

Plus Therapeutics

$2.22 /

+0.02 (+0.91%)

 
ShowHide Related Items >><<
PSTV Plus Therapeutics
$2.22 /

+0.02 (+0.91%)

PSTV Plus Therapeutics
$2.22 /

+0.02 (+0.91%)

10/16/20
Fly Intel: Top five analyst initiations
10/16/20 Maxim
Plus Therapeutics initiated with a Buy at Maxim
PSTV Plus Therapeutics
$2.22 /

+0.02 (+0.91%)

Earnings
Arthur J. Gallagher reports Q3 adjusted EPS $1.08, consensus 92c » 16:29
10/29/20
10/29
16:29
10/29/20
16:29
AJG

Arthur J. Gallagher

$103.01 /

-1.35 (-1.29%)

Reports Q3 revenue $1.8B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AJG Arthur J. Gallagher
$103.01 /

-1.35 (-1.29%)

AJG Arthur J. Gallagher
$103.01 /

-1.35 (-1.29%)

09/17/20 Deutsche Bank
Arthur J. Gallagher price target raised to $125 from $120 at Deutsche Bank
08/21/20
Fly Intel: Top five analyst downgrades
08/21/20 BofA
Arthur J. Gallagher double-downgraded to Underperform from Buy at BofA
08/21/20 BofA
Arthur J. Gallagher downgraded to Underperform from Buy at BofA
AJG Arthur J. Gallagher
$103.01 /

-1.35 (-1.29%)

AJG Arthur J. Gallagher
$103.01 /

-1.35 (-1.29%)

Earnings
Invacare raises FY20 revenue view to at least $840M from $810M-$840M » 16:28
10/29/20
10/29
16:28
10/29/20
16:28
IVC

Invacare

$7.18 /

-0.18 (-2.45%)

Consensus $826.07M.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IVC Invacare
$7.18 /

-0.18 (-2.45%)

IVC Invacare
$7.18 /

-0.18 (-2.45%)

Earnings
LeMaitre sees Q4 EPS 94c-$1.04, consensus 22c » 16:28
10/29/20
10/29
16:28
10/29/20
16:28
LMAT

LeMaitre

$35.54 /

+2.49 (+7.53%)

Sees Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LMAT LeMaitre
$35.54 /

+2.49 (+7.53%)

LMAT LeMaitre
$35.54 /

+2.49 (+7.53%)

10/28/20 Barrington
Varian Medical downgraded to Underperform from Outperform at Barrington
07/24/20 Lake Street
LeMaitre price target raised to $38 from $33 at Lake Street
05/04/20 Roth Capital
LeMaitre price target lowered to $28 from $32.50 at Roth Capital
05/01/20 Barrington
LeMaitre price target lowered to $32 from $38 at Barrington
LMAT LeMaitre
$35.54 /

+2.49 (+7.53%)

LMAT LeMaitre
$35.54 /

+2.49 (+7.53%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.